MIT Launches AI-Powered Research to Combat Antimicrobial Resistance
MIT researchers are using generative artificial intelligence and synthetic biology to develop novel treatments targeting antimicrobial resistance. The project, funded for $3 million over three years, aims to design programmable antibacterials to address a critical and growing global health threat.